Cognitive and Health Benefits of Expressive Writing for Family Caregivers Under Stress
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of this study is to determine if expressive writing is an effective intervention for reducing stress, enhancing cognition, and improving quality of life for caregivers of older adults with dementia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started May 2003
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2005
CompletedFirst Submitted
Initial submission to the registry
March 14, 2006
CompletedFirst Posted
Study publicly available on registry
March 15, 2006
CompletedMarch 15, 2006
March 1, 2006
March 14, 2006
March 14, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
General Health Questionnaire
Impact of Events Scale
Zarit Burden Interview (short form)
California Verbal Learning Test
Ruff 2 & 7 Selective Attention Test
Wechsler Adult Intelligence Scale (WAIS)
Interventions
Eligibility Criteria
You may qualify if:
- Primary family caregiver for an older adult with dementia
- Self-reported caregiver stress or burden
- Fluency in written/spoken English
You may not qualify if:
- non-family or non-primary caregiver
- existing use of expressive writing / diary
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Torontolead
- Baycrest Centre for Geriatric Carecollaborator
Study Sites (1)
University of Toronto
Toronto, Ontario, M5S 1V6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Corey S Mackenzie, Ph.D.
University of Toronto
- PRINCIPAL INVESTIGATOR
Lynn Hasher, Ph.D.
University of Toronto
- PRINCIPAL INVESTIGATOR
David Goldstein, Ph.D.
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 14, 2006
First Posted
March 15, 2006
Study Start
May 1, 2003
Study Completion
July 1, 2005
Last Updated
March 15, 2006
Record last verified: 2006-03